Unibest

Pharmaceutical intermediates

Micafungin Sodium Intermediates

1 pharmaceutical intermediate for Micafungin Sodium. Indication: Candidiasis; Fungal infection; Candidemia; Peritonitis; Pyrexia.

提交项目All intermediates

About Micafungin Sodium

Originator
Astellas Pharma Inc.
Indication
Candidiasis; Fungal infection; Candidemia; Peritonitis; Pyrexia
Approved Date
06/27/2006

Available intermediates

1 intermediate currently listed for Micafungin Sodium. Request specifications, documentation or a quotation for any item below.

Micafungin Sodium intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
4-(5-(4-(pentyloxy)phenyl)isoxazol-3-yl)benzoic acid179162-55-1//

Other programs under M

MaribavirMaxacalcitolMetoclopramide HClMilvexianMirogabalin besilateMolnupiravirMomelotinib Dihydrochloride MonohydrateMoxifloxacin hydrochloride

Building toward Micafungin Sodium?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →